WASHINGTON — President Donald Trump on Monday signed an executive order designating the street drug fentanyl a weapon of mass destruction, a move that significantly escalates the federal government’s response to drug trafficking and raises the possibility of expanded legal and military action.
The order states that fentanyl’s manufacture and distribution by organized criminal networks threatens U.S. national security and fuels instability in the Western Hemisphere. Trump said the drug’s impact on American families justified the designation.
“Two to three hundred thousand people die every year, that we know of, so we’re formally classifying fentanyl as a weapon of mass destruction,” Trump said while signing the order in the Oval Office.
Federal data show those figures are overstated. According to the Centers for Disease Control and Prevention, approximately 48,000 people in the U.S. died from fentanyl overdoses last year, a 27% decline from the year before. Overall, drug overdose deaths have been decreasing since at least 2023.
Classifying a narcotic as a weapon of mass destruction is a rare presidential action, though the idea has surfaced before. The Biden administration previously faced bipartisan pressure from attorneys general to consider such a designation because of fentanyl’s extreme potency.
The Trump administration has paired the designation with a broader militarized drug strategy, including strikes on suspected drug-running boats in the Caribbean and eastern Pacific and the classification of cartels as terrorist organizations. The administration argues these actions are saving lives, while many drug policy experts dispute their effectiveness in reducing overdose deaths.
Experts note that fentanyl is primarily manufactured by cartels in Mexico using precursor chemicals imported from China and is not typically trafficked through the maritime routes being targeted by U.S. military strikes.
Critics have also questioned the designation, citing inflated death figures and concerns that militarization could further incentivize the production of more potent synthetic drugs. Supporters argue the move is necessary to confront transnational criminal organizations and protect U.S. security.
The executive order is part of the administration’s broader national security strategy, which prioritizes combating what it describes as “narco-terrorism.”
